Literature DB >> 20198644

The specific contributions of set-shifting to freezing of gait in Parkinson's disease.

Sharon L Naismith1, James M Shine, Simon J G Lewis.   

Abstract

Freezing of gait (FOG) in Parkinson's disease (PD) is common and the pathophysiology of FOG is poorly understood. It has been hypothesized to reflect complementary yet competing frontostriatal pathways that reduce the ability to keep different tasks (motor or cognitive) on-line. This inability to "set-shift" has been proposed to trigger a freezing episode. If correct, this hypothesis would predict a differential pattern of executive dysfunction with FOG being most specifically related to attentional set-shifting. In this study, 31 patients with a range of self-reported FOG symptom severities were administered tests of executive functioning. The results demonstrate that FOG symptoms were selectively correlated with poorer performance on tasks of set-shifting, but not with a range of other executive tasks. This was apparent even after controlling for slowed processing speed, disease stage and depressive symptoms. The results support the recently proposed hypothesis for the pathophysiology underlying FOG in PD. (c) 2010 Movement Disorder Society.

Entities:  

Mesh:

Year:  2010        PMID: 20198644     DOI: 10.1002/mds.23005

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  59 in total

Review 1.  The neurobiology of falls.

Authors:  Alfonso Fasano; Meir Plotnik; Francesco Bove; Alfredo Berardelli
Journal:  Neurol Sci       Date:  2012-06-05       Impact factor: 3.307

2.  Regional gray matter atrophy in patients with Parkinson disease and freezing of gait.

Authors:  A Tessitore; M Amboni; G Cirillo; D Corbo; M Picillo; A Russo; C Vitale; G Santangelo; R Erro; M Cirillo; F Esposito; P Barone; G Tedeschi
Journal:  AJNR Am J Neuroradiol       Date:  2012-04-26       Impact factor: 3.825

3.  The role of dysfunctional attentional control networks in visual misperceptions in Parkinson's disease.

Authors:  James M Shine; Glenda M Halliday; Moran Gilat; Elie Matar; Samuel J Bolitho; Maria Carlos; Sharon L Naismith; Simon J G Lewis
Journal:  Hum Brain Mapp       Date:  2013-06-13       Impact factor: 5.038

4.  Gait bradykinesia in Parkinson's disease: a change in the motor program which controls the synergy of gait.

Authors:  Tateo Warabi; Hiroyasu Furuyama; Eri Sugai; Masamichi Kato; Nobuo Yanagisawa
Journal:  Exp Brain Res       Date:  2017-10-27       Impact factor: 1.972

5.  Identifying the neural correlates of doorway freezing in Parkinson's disease.

Authors:  Elie Matar; James M Shine; Moran Gilat; Kaylena A Ehgoetz Martens; Philip B Ward; Michael J Frank; Ahmed A Moustafa; Sharon L Naismith; Simon J G Lewis
Journal:  Hum Brain Mapp       Date:  2019-01-13       Impact factor: 5.038

6.  The role of the prefrontal cortex in freezing of gait in Parkinson's disease: insights from a deep repetitive transcranial magnetic stimulation exploratory study.

Authors:  Moria Dagan; Talia Herman; Anat Mirelman; Nir Giladi; Jeffrey M Hausdorff
Journal:  Exp Brain Res       Date:  2017-05-16       Impact factor: 1.972

7.  Co-treatment with rivastigmine and idalopirdine reduces the propensity for falls in a rat model of falls in Parkinson's disease.

Authors:  Ajeesh Koshy Cherian; Aaron Kucinski; Ryan Wu; Inge E M de Jong; Martin Sarter
Journal:  Psychopharmacology (Berl)       Date:  2019-01-04       Impact factor: 4.530

8.  Cognitive Contributions to Freezing of Gait in Parkinson Disease: Implications for Physical Rehabilitation.

Authors:  Daniel S Peterson; Laurie A King; Rajal G Cohen; Fay B Horak
Journal:  Phys Ther       Date:  2015-09-17

Review 9.  Cognitive aspects of freezing of gait in Parkinson's disease: a challenge for rehabilitation.

Authors:  Elke Heremans; A Nieuwboer; J Spildooren; J Vandenbossche; N Deroost; E Soetens; E Kerckhofs; S Vercruysse
Journal:  J Neural Transm (Vienna)       Date:  2013-01-18       Impact factor: 3.575

Review 10.  Where attention falls: Increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function.

Authors:  Martin Sarter; Roger L Albin; Aaron Kucinski; Cindy Lustig
Journal:  Exp Neurol       Date:  2014-05-05       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.